Resistance of Escherichia coli and Salmonella against nisin and curvacin A.
We have determined the effects of the following factors on the resistance of Gram-negative bacteria against nisin and curvacin A: (i) chemotype of the lipopolysaccharide (LPS), (ii) addition of agents permeabilizing the outer membrane, (iii) the fatty acid supply of the growth medium, and (iv) the adaptation to acid and salt stress. Bacteriocin activity was determined against growing and resting cells as well as protoplasts. All smooth strains of Escherichia coli and Salmonella enterica serovar Typhimurium were highly resistant towards the bacteriocins, whereas mutants that possess the core of the LPS, but not the O antigen, as well as deep rough LPS mutants were sensitive. Antibiotics with outer membrane permeabilizing activity, polymyxin B and polymyxin B nonapeptide, increased the sensitivity of smooth E. coli towards nisin, but not that of deep rough mutants. Incorporation of 1 g l(-1) of either oleic acid or linoleic acid to the growth media greatly increased the susceptibility of E. coli LTH1600 and LTH4346 towards bacteriocins. Both strains of E. coli were sensitive to nisin and curvacin A at a pH of less than 5.5 and more than 3% (w/v) NaCl. Adaptation to sublethal pH or higher NaCl concentrations (pH 4.54 and 5.35 or 4.5% (w/v) NaCl) provided only limited protection against the bacteriocidal activity of nisin and curvacin A. Adaptation to 4.5% (w/v) NaCl did not result in cross protection to bacteriocin activity at pH 4.4, but rendered the cells more sensitive towards bacteriocins.
Gänzle
M G
MG
Universität Hohenheim, Institut für Lebensmitteltechnologie (ALT), Stuttgart, Germany.
Hertel
C
C
Hammes
W P
WP
D000900:Anti-Bacterial Agents / Q000378:metabolism; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics; D001430:Bacteriocins / Q000378:metabolism* / Q000494:pharmacology; D002463:Cell Membrane Permeability; D004352:Drug Resistance, Microbial; D019453:Escherichia coli O157 / Q000187:drug effects / Q000235:genetics / Q000254:growth & development*; D005520:Food Preservatives / Q000378:metabolism* / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D019787:Linoleic Acid / Q000378:metabolism; D008070:Lipopolysaccharides / Q000737:chemistry; D009154:Mutation; D009561:Nisin / Q000378:metabolism* / Q000494:pharmacology; D019301:Oleic Acid / Q000378:metabolism; D011112:Polymyxin B / Q000378:metabolism; D011523:Protoplasts / Q000187:drug effects / Q000378:metabolism; D019779:Salmonella enterica / Q000187:drug effects / Q000235:genetics / Q000254:growth & development*; D012965:Sodium Chloride / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001425:Bacterial Outer Membrane Proteins; D001430:Bacteriocins; D005520:Food Preservatives; D008070:Lipopolysaccharides; C071456:sakacin A; D009561:Nisin; D019301:Oleic Acid; D012965:Sodium Chloride; D019787:Linoleic Acid; D011112:Polymyxin B